TCM
ISEE

Tang Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Tang Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-250,000
Closed -$2.15M – 28
2019
Q4 		$2.15M Sell
250,000
-350,000
-58% -$1.25M 0.26% 14
2019
Q3 		$672K Hold
600,000
– – 0.12% 11
2019
Q2 		$780K Hold
600,000
– – 0.11% 10
2019
Q1 		$846K Hold
600,000
– – 0.16% 8
2018
Q4 		$720K Buy
+600,000
New +$1.16M 0.17% 6

Other funds holding ISEE

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BCM
Burrage Capital Management Boston, Massachusetts $99.7M AUM 66.05% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Tang Capital Management's ISEE Position: Q1 2020 in Review

Tang Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2020, closing a stake of 250,000 shares — an estimated $2.15M sold.

Tang Capital Management first reported a position in ISEE in Q4 2018 and held it in 5 quarters. The position peaked at $2.15M in Q4 2019. 75 funds tracked by Wall St. Rank hold ISEE as of Q1 2020.

  • Tang Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Tang Capital Management sold 250,000 IVERIC bio, Inc. Common Stock shares in Q1 2020, an estimated $2.15M.
  • Tang Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2018 and held it in 5 quarters.
  • Tang Capital Management's IVERIC bio, Inc. Common Stock position peaked at $2.15M in Q4 2019.
  • 75 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2020.

Based on Tang Capital Management's 13F filing for Q1 2020, filed 15 May 2020.